{
  "retracted": false,
  "timestamp": 1522540800000,
  "updates": [
    {
      "timestamp": 1584951800387,
      "identifier": {
        "doi": "10.1016/j.eururo.2017.12.016"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.eururo.2017.02.010"
  },
  "publisher": "Elsevier BV",
  "title": "Erratum to “CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962–71]"
}
